Dermatologic agents during pregnancy and lactation: an update and clinical review

被引:39
作者
Hale, EK [1 ]
Pomeranz, MK [1 ]
机构
[1] NYU, Sch Med, Dept Dermatol, New York, NY 10016 USA
关键词
D O I
10.1046/j.1365-4362.2002.01464.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
[No abstract available]
引用
收藏
页码:197 / 203
页数:7
相关论文
共 32 条
  • [1] *AM COLL OBST GYN, 1994, TECHN B AM COLL OBST, V193
  • [2] [Anonymous], 1999, MED LETT DRUGS THER, V41, P85
  • [3] Boothby LA, 2001, ANN PHARMACOTHER, V35, P1485
  • [4] BRANSKI D, 1986, J PEDIATR GASTR NUTR, V5, P316, DOI 10.1097/00005176-198605020-00028
  • [5] Briggs G., 1998, DRUGS PREGNANCY LACT, V5th
  • [6] Buck H W, 1998, Infect Dis Obstet Gynecol, V6, P49, DOI 10.1155/S106474499800012X
  • [7] EPIDEMIOLOGY OF ISOTRETINOIN EXPOSURE DURING PREGNANCY
    DAI, WS
    LABRAICO, JM
    STERN, RS
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1992, 26 (04) : 599 - 606
  • [8] Prospective controlled study of hydroxyzine and cetirizine in pregnancy
    Einarson, A
    Bailey, B
    Jung, G
    Spizzirri, D
    Baillie, M
    Koren, G
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1997, 78 (02) : 183 - 186
  • [9] COX-2-specific inhibitors -: the emergence of a new class of analgesic and anti-inflammatory drugs
    Everts, B
    Währborg, P
    Hedner, T
    [J]. CLINICAL RHEUMATOLOGY, 2000, 19 (05) : 331 - 343
  • [10] HARAHAP M, 1996, SKIN CHANGES DIS PRE, P321